SCHEMBL4442926

SCHEMBL4442926

Nc1ccc(F)cc1.O=C(CO)Nc1c[nH]nc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.44
ALDH1A1 P00352 3/20 0.34
CCNA2 P20248 1/20 0.34
HSD17B10 Q99714 2/20 0.33
TSHR P16473 1/20 0.33
HDAC1 Q13547 2/20 0.33
ADORA3 P0DMS8 2/20 0.32
HDAC3 O15379 1/20 0.32
ADORA2A P29274 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
KCNQ3 O43525 1/20 0.32
KCNQ2 O43526 1/20 0.32
ABCB11 O95342 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803444 0.85 CDK2 (0.37) CDK2ALDH1A1LMNAHCAR2
SCHEMBL3940057 0.82 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL4450271 0.81 HDAC1 (0.53) CDK2ALDH1A1CCNA2HSD17B10TSHR
SCHEMBL3938054 0.81 ALDH1A1 (0.53) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL3937442 0.80 CFTR (0.35) HSD17B10HDAC1ADORA3HDAC3KCNQ3
SCHEMBL3942467 0.80 CDK2 (0.48) CDK2CCNA2HDAC1LMNAMEN1
SCHEMBL4343632 0.80 LRRK2 (0.36) ALDH1A1HPGDMAPK1
SCHEMBL959184 0.80 CDK2 (0.58) CDK2ALDH1A1CCNA2MEN1KMT2A
SCHEMBL3937668 0.79 ATM (0.55) ALDH1A1HDAC3TDP1LMNAHPGD
SCHEMBL3939511 0.79 LMNA (0.48) ALDH1A1TSHRHDAC1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049106-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2008007113-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed